Phase 1 pharmacokinetic and drug‐interaction study of dasatinib in patients with advanced solid tumors
Johnson, Faye M., Agrawal, Shruti, Burris, Howard, Rosen, Lee, Dhillon, Navneet, Hong, David, Blackwood‐Chirchir, Anne, Luo, Feng R., Sy, Oumar, Kaul, Sanjeev, Chiappori, Alberto A.
Published in Cancer (15.03.2010)
Published in Cancer (15.03.2010)
Get full text
Journal Article
Silent infarcts in young children with sickle cell disease
Kwiatkowski, Janet L., Zimmerman, Robert A., Pollock, Avrum N., Seto, Wendy, Smith‐Whitley, Kim, Shults, Justine, Blackwood‐Chirchir, Anne, Ohene‐Frempong, Kwaku
Published in British journal of haematology (01.08.2009)
Published in British journal of haematology (01.08.2009)
Get full text
Journal Article
Metabolism and Disposition of Dasatinib after Oral Administration to Humans
Lisa J. Christopher, Donghui Cui, Chiyuan Wu, Roger Luo, James A. Manning, Samuel J. Bonacorsi, Michael Lago, Alban Allentoff, Francis Y. F. Lee, Betty McCann, Susan Galbraith, Donald P. Reitberg, Kan He, Anthony Barros, Jr, Anne Blackwood-Chirchir, W. Griffith Humphreys, Ramaswamy A. Iyer
Published in Drug metabolism and disposition (01.07.2008)
Published in Drug metabolism and disposition (01.07.2008)
Get full text
Journal Article
Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects
Eley, Timothy, Luo, Feng R, Agrawal, Shruti, Sanil, Ashish, Manning, James, Li, Tong, Blackwood-Chirchir, Anne, Bertz, Richard
Published in Journal of clinical pharmacology (01.06.2009)
Published in Journal of clinical pharmacology (01.06.2009)
Get more information
Journal Article
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma
Kruper, Laura L., Spitz, Francis R., Czerniecki, Brian J., Fraker, Douglas L., Blackwood‐Chirchir, Anne, Ming, Michael E., Elder, David E., Elenitsas, Rosalie, Guerry, DuPont, Gimotty, Phyllis A.
Published in Cancer (15.11.2006)
Published in Cancer (15.11.2006)
Get full text
Journal Article
Checkmate 816: A phase 3, randomized, open-label trial of nivolumab plus ipilimumab vs platinum-doublet chemotherapy as neoadjuvant treatment for early-stage NSCLC
Forde, Patrick M., Chaft, Jamie E., Felip, Enriqueta, Broderick, Stephen, Girard, Nicolas, Awad, Mark M., Kerr, Keith, Blackwood-Chirchir, Anne, Yang, Rong, Geese, William J., Brahmer, Julie R.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure
LUO, Feng R, ZHENG YANG, WEN, Mei-Li, KRAMER, Robert, BLACKWOOD-CHIRCHIR, Anne, LEE, Francis Y, CAMUSO, Amy, SMYKLA, Richard, MCGLINCHEY, Kelly, FAGER, Krista, FLEFLEH, Christine, CASTANEDA, Stephen, INIGO, Ivan, KAN, David
Published in Clinical cancer research (01.12.2006)
Published in Clinical cancer research (01.12.2006)
Get full text
Journal Article
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
Talpaz, Moshe, Shah, Neil P, Kantarjian, Hagop, Donato, Nicholas, Nicoll, John, Paquette, Ron, Cortes, Jorge, O'Brien, Susan, Nicaise, Claude, Bleickardt, Eric, Blackwood-Chirchir, M. Anne, Iyer, Vishwanath, Chen, Tai-Tsang, Huang, Fei, Decillis, Arthur P, Sawyers, Charles L
Published in The New England journal of medicine (15.06.2006)
Published in The New England journal of medicine (15.06.2006)
Get full text
Journal Article
Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease
Raffini, Leslie J., Niebanck, Alison E., Hrusovsky, Joanne, Stevens, Amanda, Blackwood-Chirchir, Anne, Ohene-Frempong, Kwaku, Kwiatkowski, Janet L.
Published in Pediatric blood & cancer (15.10.2006)
Published in Pediatric blood & cancer (15.10.2006)
Get full text
Journal Article
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Horn, Leora, Spigel, David R, Vokes, Everett E, Holgado, Esther, Ready, Neal, Steins, Martin, Poddubskaya, Elena, Borghaei, Hossein, Felip, Enriqueta, Paz-Ares, Luis, Pluzanski, Adam, Reckamp, Karen L, Burgio, Marco A, Kohlhäeufl, Martin, Waterhouse, David, Barlesi, Fabrice, Antonia, Scott, Arrieta, Oscar, Fayette, Jérôme, Crinò, Lucio, Rizvi, Naiyer, Reck, Martin, Hellmann, Matthew D, Geese, William J, Li, Ang, Blackwood-Chirchir, Anne, Healey, Diane, Brahmer, Julie, Eberhardt, Wilfried E E
Published in Journal of clinical oncology (10.12.2017)
Published in Journal of clinical oncology (10.12.2017)
Get full text
Journal Article
Iniparib in Metastatic Triple-Negative Breast Cancer
Domagala, Pawel, Lubinski, Jan, Domagala, Wenancjusz
Published in The New England journal of medicine (05.05.2011)
Published in The New England journal of medicine (05.05.2011)
Get full text
Journal Article
Abstract CT126: Soluble HLA-G and -E (sHLA-G/E) as potential biomarkers of clinical outcomes in patients (pts) with advanced, refractory squamous (SQ) NSCLC treated with nivolumab (NIVO): CheckMate 063
Rebmann, Vera, Eberhardt, Wilfried E., Rizvi, Naiyer, Antonia, Scott J., Planchard, David, Cappuzzo, Federico, Mazières, Julien, Zalcman, Gérard, Lena, Hervé, Wolf, Jürgen, Horn, Leora, Stinchcombe, Thomas, Dy, Grace, Blackwood-Chirchir, Anne, Jin, Chelsea, Geese, William J., Ramalingam, Suresh S.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Nivolumab (nivo) in patients (pts) with advanced (adv) NSCLC and central nervous system (CNS) metastases (mets)
Goldman, Jonathan Wade, Crino, Lucio, Vokes, Everett E., Holgado, Esther, Reckamp, Karen L., Pluzanski, Adam, Spigel, David R., Kohlhaeufl, Martin, Garassino, Marina Chiara, Chow, Laura Quan Man, Gettinger, Scott N., Gerber, David E., Havel, Libor, Ramalingam, Suresh S., Dy, Grace K., Geese, William J., Li, Ang, Blackwood-Chirchir, Anne, Healey, Diane I., Brahmer, Julie R.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Abstract A120: A Phase Ib study of CC-486 (Oral Azacitidine) as a priming agent for carboplatin or NAB-paclitaxel in subjects with relapsed and refractory solid tumors
LoRusso, Patricia, Rasco, Drew, Bendell, Johanna, Sachdev, Jasgit, Ramanathan, Ramesh, Weiss, Glenn, Munster, Pamela, Edenfield, William J., Liu, Kejian, Blackwood-Chirchir, Anne, DiMartino, Jorge, Von Hoff, Daniel D.
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article
P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets)
Goldman, Jonathan W., Crino, Lucio, Vokes, Everett E., Holgado, Esther, Reckamp, Karen, Pluzanski, Adam, Spigel, David, Kohlhaeufl, Martin, Garassino, Marina, Chow, Laura Qm, Gettinger, Scott, Gerber, David E., Havel, Libor, Ramalingam, Suresh S., Dy, Grace K., Geese, William J., Li, Ang, Blackwood-Chirchir, Anne, Healey, Diane, Brahmer, Julie, Lopes, Gilberto
Published in Journal of thoracic oncology (01.10.2016)
Published in Journal of thoracic oncology (01.10.2016)
Get full text
Journal Article
P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets): Track: Immunotherapy
Goldman, Jonathan W., Crino, Lucio, Vokes, Everett E., Holgado, Esther, Reckamp, Karen, Pluzanski, Adam, Spigel, David, Kohlhaeufl, Martin, Garassino, Marina, Chow, Laura Qm, Gettinger, Scott, Gerber, David E., Havel, Libor, Ramalingam, Suresh S., Dy, Grace K., Geese, William J., Li, Ang, Blackwood-Chirchir, Anne, Healey, Diane, Brahmer, Julie, Lopes, Gilberto
Published in Journal of thoracic oncology (01.10.2016)
Published in Journal of thoracic oncology (01.10.2016)
Get full text
Journal Article
Abstract B217: A Phase I study of CC-486 (oral azacitidine) to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of azacitidine administered alone and in combination with carboplatin or ABI-007 (NAB-paclitaxel) in subjects with solid tumors
Laille, Eric, Nguyen, Aaron N., Chen, Gengxi, Rasco, Drew, LoRusso, Patricia, Von Hoff, Daniel D., Bendell, Johanna, Munster, Pamela, Edenfield, William J., Ramanathan, Ramesh, Gonzalez, Michael B., Blackwood-Chirchir, Anne, DiMartino, Jorge
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article
Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL™), a multi-targeted kinase inhibitor
Luo, Feng (Roger), Barrett, Yu Chen, Yang, Zheng, Camuso, Amy, McGlinchey, Kelly, Wen, Mei-Li, Smykla, Richard, Fager, Krista, Wild, Robert, Palme, Holly, Galbraith, Susan, Blackwood-Chirchir, Anne, Lee, Francis Y.
Published in Cancer chemotherapy and pharmacology (01.11.2008)
Published in Cancer chemotherapy and pharmacology (01.11.2008)
Get full text
Journal Article
Dasatinib Can Be Administered Orally with or without a Meal
Kaul, Sanjeev, Wu, Chiyuan, Mayfield, Shelley, Manning, James, Blackwood-Chirchir, Anne
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article